首页> 美国卫生研究院文献>Clinical Molecular Pathology >Present significance of resistance to trimethoprim and sulphonamides in coliforms Staphylococcus aureus and Streptococcus faecalis
【2h】

Present significance of resistance to trimethoprim and sulphonamides in coliforms Staphylococcus aureus and Streptococcus faecalis

机译:目前对大肠菌群金黄色葡萄球菌和粪链球菌对甲氧苄氨嘧啶和磺酰胺类耐药的重要意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The incidence of trimethoprim resistance in coliforms and multiresistant strains of Staphylococcus aureus isolated in Bristol from 1970 to 1972 is low—2·3 and 1·0% respectively. The resistance is probably intrinsic; there is no evidence that it is R-factor or plasmid mediated. A single mechanism that confers resistance to both trimethoprim and sulphamethoxazole has not been detected. Normal growing one-step mutants of S. aureus and Escherichia coli resistant to trimethoprim could not be isolated in vitro. For these reasons cotrimoxazole should retain its usefulness against these bacteria for some years. However, contrimoxazole was found not to be bactericidal against many coliforms.The usefulness of cotrimoxazole against Streptococcus faecalis seems limited because mutants resistant to trimethoprim occurred at high frequency in one step.
机译:1970年至1972年在布里斯托尔分离的大肠菌群和金黄色葡萄球菌多耐药株对甲氧苄啶的耐药率较低,分别为2·3和1·0%。阻力可能是内在的;没有证据表明它是由R因子或质粒介导的。尚未发现对甲氧苄啶和磺胺甲恶唑都有抗药性的单一机制。不能分离出对甲氧苄啶具有抗性的正常生长的金黄色葡萄球菌和大肠杆菌的一步一步突变体。由于这些原因,cotrimoxazole应该对这些细菌保持有用数年。然而,发现曲莫唑对许多大肠菌并不具有杀菌作用。由于对甲氧苄啶具有抗性的突变体以高频率一步发生,因此考莫唑对粪便链球菌的作用似乎有限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号